The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EHA 2026 | Guidance for community oncologists navigating the AML treatment landscape
Yakir Moshe, MD, PhD, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, provides advice to community oncologists outside large academic centers who are navigating the increasingly complex landscape of acute myeloid leukemia (AML) treatment. Dr Moshe highlights the value of pooling data, discussing patient care, and staying up to date with the latest research. This interview took place at the 31st Congress of the European Hematology Association (EHA) in Stockholm, Sweden.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
